Specifically activated dendritic cells--cell-based vaccine against lymphosarcoma exhibiting multiple drug resistance phenotype

Dokl Biochem Biophys. 2009 Sep-Oct:428:252-6. doi: 10.1134/s1607672909050081.

Authors

N L Mironova¹, E E Panzinskyi, N A Popova, V P Nikolin, M A Zenkova, V V Vlasov

Affiliation

¹ Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, pr. Akademika Lavrent'eva 8, Novosibirsk 630090, Russia.

PMID: 20848912
DOI: 10.1134/s1607672909050081

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
Animals
Cancer Vaccines / immunology*
Cell Line, Tumor
Dendritic Cells / immunology*
Dendritic Cells / metabolism
Drug Resistance, Multiple*
Drug Resistance, Neoplasm* / genetics
Humans
Lymphoma, Non-Hodgkin / genetics
Lymphoma, Non-Hodgkin / immunology*
Lymphoma, Non-Hodgkin / therapy
Mice
Phenotype*
RNA, Messenger / genetics
T-Lymphocytes, Cytotoxic / immunology
Transfection

Substances

ATP Binding Cassette Transporter, Subfamily B, Member 1
Cancer Vaccines
RNA, Messenger